Search

Search Constraints

You searched for: Author/Creator Furling, Denis

Search Results

1. Activation of the interferon type I response rather than autophagy contributes to myogenesis inhibition in congenital DM1 myoblasts. Issue 11 (November 2018)

2. Association Between Mutation Size and Cardiac Involvement in Myotonic Dystrophy Type 1: An Analysis of the DM1-Heart Registry. (June 2017)

3. CRISPR gene editing in pluripotent stem cells reveals the function of MBNL proteins during human in vitro myogenesis. Issue 1 (26th July 2021)

4. Desmin prevents muscle wasting, exaggerated weakness and fragility, and fatigue in dystrophic mdx mouse. (1st July 2020)

5. Dystrophin restoration therapy improves both the reduced excitability and the force drop induced by lengthening contractions in dystrophic mdx skeletal muscle. Issue 1 (December 2016)

7. Efficient CRISPR/Cas9-mediated editing of trinucleotide repeat expansion in myotonic dystrophy patient-derived iPS and myogenic cells. Issue 16 (27th June 2018)

8. High Risk of Fatal and Nonfatal Venous Thromboembolism in Myotonic Dystrophy. Issue 11 (11th September 2018)

9. Lentiviral vector-mediated overexpression of mutant ataxin-7 recapitulates SCA7 pathology and promotes accumulation of the FUS/TLS and MBNL1 RNA-binding proteins. Issue 1 (December 2016)

10. MBNL‐dependent impaired development within the neuromuscular system in myotonic dystrophy type 1. Issue 1 (17th January 2023)